Gurmit Singh Chugh

Gurmit Singh Chugh

Active Director Director DIN 00821824
DIN 00821824 First appointment Apr 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 13 active board seats
Past companies 4 historical roles
Total affiliations 17 Since Apr 2004
Shareholding value •••• Premium profile

About Gurmit Singh Chugh

Data last updated:

Gurmit Singh Chugh is a Director at Integris Medtech Limited (since 2008), Whole-Time Director at Transhealth Private Limited (since 2020) and Director at Aerobiotix Global Private Limited (since 2025), and holds 10 more current directorships. The companies operate in Healthcare, Consumer Services and Financial Services. The 8 current companies with reported revenue have a combined latest revenue of ₹2,016 Cr; the largest is Integris Medtech Limited at ₹1,960 Cr (FY 2025). Earlier, Gurmit Singh Chugh was a Director at Ae-Research Private Limited (2009–2012) and Director at Translumina Therapeutics Private Limited (from 2009) and 2 more.

DIN 00821824
Primary Designation Director
Industry Healthcare
First Appointment 01 Apr 2004
Oldest Company Age 30 yrs
Largest company Integris Medtech Limited · ₹1,960 Cr (FY 2025)
Combined revenue ₹2,016 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Integris Medtech Limited U85110DL2008PLC177230
Director25 Apr 20082008₹1,960 Cr (FY 2025)Active
Transhealth Private Limited U33309DL2020PTC364238
Whole-Time Director02 Jun 20202020₹38.92 Cr (FY 2024)Active
Aerobiotix Global Private Limited U51900DL2019PTC345086
Director06 Sep 20252019₹8.97 Cr (FY 2024)Active
Halemed Medical Private Limited U24296UR2021PTC012917
Director24 Jun 20252021₹5.46 Cr (FY 2024)Active
Whitestone Estate Private Limited U52339DL2021PTC380365
Director20 Apr 20212021₹1.94 Cr (FY 2024)Active
Mint Retails Private Limited U52399UR2022PTC014539
Director31 Aug 20222022₹1.28 Cr (FY 2025)Active
Director28 Feb 20221996₹85,367 (FY 2021)Active
Transvalve Health Private Limited U33100DL2021PTC389727
Director11 Nov 20212021₹10,000 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ae-Research Private Limited U74140DL2009PTC193058
Director11 Aug 20092009₹6.11 Cr (FY 2024)Active
Director21 Oct 20092009Converted To Llp
Advance Therapeutics Private Limited U33112DL2002PTC113960
Managing Director01 Apr 20042002₹2 Lakh (FY 2023)Converted To Llp
Partner17 May 20192009₹376 Cr (FY 2023)Converted And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pathway Medical Llp
Transvalve Health Private Limited
Translumina Therapeutics Private Limited
Advance Therapeutics Private Limited
Premium access

Shareholding and investment profile for Gurmit Singh Chugh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurmit Singh Chugh

Gurmit Singh Chugh currently holds 13 directorships: Integris Medtech Limited (Director, since 25 Apr 2008, revenue ₹1,960 Cr (FY 2025)); Transhealth Private Limited (Whole-Time Director, since 02 Jun 2020, revenue ₹38.92 Cr (FY 2024)); Aerobiotix Global Private Limited (Director, since 06 Sep 2025, revenue ₹8.97 Cr (FY 2024)); Halemed Medical Private Limited (Director, since 24 Jun 2025, revenue ₹5.46 Cr (FY 2024)); Whitestone Estate Private Limited (Director, since 20 Apr 2021, revenue ₹1.94 Cr (FY 2024)); and 8 more.

Gurmit Singh Chugh was first appointed on 01 Apr 2004 as Managing Director at Advance Therapeutics Private Limited. The most recent appointment on record is 17 Sep 2025 at Translumina Therapeutics Private Limited.

The 8 current companies of Gurmit Singh Chugh that report revenue have a combined latest revenue of ₹2,016 Cr: Integris Medtech Limited ₹1,960 Cr (FY 2025); Transhealth Private Limited ₹38.92 Cr (FY 2024); Aerobiotix Global Private Limited ₹8.97 Cr (FY 2024); Halemed Medical Private Limited ₹5.46 Cr (FY 2024); Whitestone Estate Private Limited ₹1.94 Cr (FY 2024); and 3 more.

Gurmit Singh Chugh held 4 earlier board appointments: Ae-Research Private Limited (Director, 11 Aug 2009 to 17 Dec 2012); Translumina Therapeutics Private Limited (Director, from 21 Oct 2009); Advance Therapeutics Private Limited (Managing Director, from 01 Apr 2004); Translumina Therapeutics Llp (Partner, from 17 May 2019).

The current boards of Gurmit Singh Chugh's companies include Annaswamy Vaidheesh (Integris Medtech Limited), Arjun Oberoi (Integris Medtech Limited), Avnish Mehra (Integris Medtech Limited), Darpan Batra (Integris Medtech Limited), Hemant Sultania (Integris Medtech Limited), Probir Das (Integris Medtech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available